United States · Federal contract register · Supplier record

AVANTI POLAR LIPIDS, LLC

Line: Pharmacy services (Q517)Register loaded to September 2026Compiled 7 October 2026

AVANTI POLAR LIPIDS, LLC — United States · Federal contract register · Supplier record: 62 contracts, all years ($584,577 · May 2004 – Jul 2024); $280K since January 2024 (2 contracts · 2 agencies); 79th rank in the line (of 147 suppliers · 0.07%); 3 agencies never served ($8.9M on the line without AVANTI POLAR LIPIDS, LLC).

Assay record ASY-US-0J6I4VA146 · Cite as: Assay Systems, “AVANTI POLAR LIPIDS, LLC in the USAspending register”, https://assay-systems.com/register/us/avanti-polar-lipids-llc/

62
contracts, all years
$584,577 · May 2004 – Jul 2024
$280K
since January 2024
2 contracts · 2 agencies
79th
rank in the line
of 147 suppliers · 0.07%
3
agencies never served
$8.9M on the line without AVANTI POLAR LIPIDS, LLC

Own record by year

2020 onward
$30.1K
$11.4K
$12.3K
$280K
2020202120222023202420252026

Who buys from AVANTI POLAR LIPIDS, LLC

since January 2024
2agencies
$280Kpaid
89.5%top buyer
Department of Defense89.5%
$250,654
Department of Health and Human Services10.5%
$29,305

Before 2024 only: Department of Commerce, Department of Veterans Affairs.

The line

since January 2024
$358Mline value
652contracts
6agencies
147suppliers
65.2%held by top ten

Pharmacy services (Q517)

$133M
$112M
$113M
202420252026Jan–Sep
79thof 147 suppliers
$250,654AVANTI POLAR LIPIDS, LLC in the line
0.07%share of the line
0.3%of $86,763,647 spent by Department of Defense

Agencies that buy the line and never bought from AVANTI POLAR LIPIDS, LLC

3agencies
233contracts
$8,870,527since January 2024
Department of Justice230 contracts
$7,711,093
Department of the Interior2 contracts
$631,491
Department of the Treasury1 contract
$527,943

How the line is bought

by value, since 2024
7%no competition
4%one applicant
0of these to AVANTI POLAR LIPIDS, LLC
Competed, several suppliers applied380 contracts
$321,250,142 · 89.7%
Awarded directly, no competition120 contracts
$24,299,399 · 6.8%
Competed, one supplier applied152 contracts
$12,582,591 · 3.5%

Contracts reaching their end dates

Oct 2026 – October 2027
148contracts
$150,425,762end by October 2027
27end in March 2027 · $20.1M
12in agencies never served · $675K
$4.6M
$14.6M
$5.8M
$2.0M
$32.9M
$20.1M
$2.1M
$601K
$32.3M
$21.6M
$988K
$12.9M
Oct 2610 contractsNov 2610 contractsDec 2613 contractsJan 2710 contractsFeb 276 contractsMar 2727 contractsApr 2713 contractsMay 272 contractsJun 2710 contractsJul 2724 contractsAug 276 contractsSep 2717 contracts

Suppliers next to it in the line

since January 2024
BOSTON SCIENTIFIC CORP4 contracts · 1 agency
$255,120
AVANTI POLAR LIPIDS, LLC
$250,654
KINIKSA PHARMACEUTICALS (UK), LTD.4 contracts · 1 agency
$248,516
AMG COMPANY, INC.1 contract · 1 agency
$244,005

All 147 suppliers in the line

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.